GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » Operating Margin %

Changzhou Qianhong Biopharma Co (SZSE:002550) Operating Margin % : 28.61% (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Changzhou Qianhong Biopharma Co's Operating Income for the three months ended in Mar. 2025 was ¥129 Mil. Changzhou Qianhong Biopharma Co's Revenue for the three months ended in Mar. 2025 was ¥451 Mil. Therefore, Changzhou Qianhong Biopharma Co's Operating Margin % for the quarter that ended in Mar. 2025 was 28.61%.

Good Sign:

Changzhou Qianhong Biopharma Co Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Changzhou Qianhong Biopharma Co's Operating Margin % or its related term are showing as below:

SZSE:002550' s Operating Margin % Range Over the Past 10 Years
Min: 8.66   Med: 12.75   Max: 26.19
Current: 20.05


SZSE:002550's Operating Margin % is ranked better than
83.13% of 972 companies
in the Drug Manufacturers industry
Industry Median: 6.895 vs SZSE:002550: 20.05

Changzhou Qianhong Biopharma Co's 5-Year Average Operating Margin % Growth Rate was 1.20% per year.

Changzhou Qianhong Biopharma Co's Operating Income for the three months ended in Mar. 2025 was ¥129 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥304 Mil.


Changzhou Qianhong Biopharma Co Operating Margin % Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co Operating Margin % Chart

Changzhou Qianhong Biopharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.60 8.66 10.78 9.15 19.29

Changzhou Qianhong Biopharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.91 20.91 15.72 11.67 28.61

Competitive Comparison of Changzhou Qianhong Biopharma Co's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Changzhou Qianhong Biopharma Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changzhou Qianhong Biopharma Co's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changzhou Qianhong Biopharma Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Changzhou Qianhong Biopharma Co's Operating Margin % falls into.


;
;

Changzhou Qianhong Biopharma Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Changzhou Qianhong Biopharma Co's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=294.482 / 1526.243
=19.29 %

Changzhou Qianhong Biopharma Co's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=128.986 / 450.88
=28.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changzhou Qianhong Biopharma Co  (SZSE:002550) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Changzhou Qianhong Biopharma Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Changzhou Qianhong Biopharma Co Business Description

Traded in Other Exchanges
N/A
Address
Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.
Executives
Huang Jie Executives
Wang Ke Directors, executives
Jiang Wen Qun Supervisors
Zou Shao Bo Executives
Wei Li Jun Executives
Mei Chun Wei Executives
Zhou Xiang Directors, executives
Zhao Gang Director
Ye Hong Ping Executives
Liu Jun Director
Fan Yong Executives
Jiang Jian Ping Supervisors
Wang Yao Fang Director
Hai Tao Directors, executives
Wang Yi Director

Changzhou Qianhong Biopharma Co Headlines

No Headlines